RUBY

Rubius Therapeutics, Inc

Delisted

RUBY was delisted on the 6th of March, 2023.

42 hedge funds and large institutions have $11.2M invested in Rubius Therapeutics, Inc in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-20
Holders Change %
-32.26%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
10
Reduced
15
Closed
24
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Two Sigma Advisers
51
Two Sigma Advisers
New York
-$13K -29,400 Closed
Jane Street
52
Jane Street
New York
-$10K -23,784 Closed
LP
53
LMR Partners
United Kingdom
-$9K -21,844 Closed
HF
54
HRT Financial
New York
-$8K -20,425 Closed
OQS
55
Occudo Quantitative Strategies
Florida
-$9K -19,975 Closed
CSS
56
Cubist Systematic Strategies
Connecticut
-$8K -18,270 Closed
SSA
57
Schonfeld Strategic Advisors
New York
-$6K -15,100 Closed
VPIM
58
Vanguard Personalized Indexing Management
California
-$5K -10,753 Closed
Principal Financial Group
59
Principal Financial Group
Iowa
-$5K -10,417 Closed
QT
60
Quantbot Technologies
New York
-$1K -4,400 Closed
PHK
61
Point72 Hong Kong
Hong Kong
-$1K -1,735 Closed